Once-Monthly Oral PrEP Option Appears Safe, Tolerable in Adults at Low Risk of HIV



(MedPage Today) — The investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to placebo, with dose-proportional pharmacokinetics, among adults with a low likelihood of HIV-1 exposure…



Source link : https://www.medpagetoday.com/meetingcoverage/ias/116568

Author :

Publish date : 2025-07-18 14:50:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version